Panacinar Emphysema
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
1997 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
22
|
33
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Micronuclei, Chromosome-Defective
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell Component
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Micronuclei, Genotoxicant-Induced
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell Component
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
38
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Lymphoma, Diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Focal Emphysema
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
1997 |
1997 |
L2 Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
50
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Acute Myeloid Leukemia (AML-M2)
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
5
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic Airflow Obstruction
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
33
|
|
0.300 |
None |
1.000 |
1 |
|
1997 |
1997 |
Acute Lung Injury
|
disease |
Respiratory Tract Diseases
|
Injury or Poisoning
|
22
|
3
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
High Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Amphetamine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
75
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Skin Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
59
|
2
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Acute Myeloid Leukemia, M1
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
155
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Animal Mammary Neoplasms
|
phenotype |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
142
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Lymphoma, Undifferentiated
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Lymphoma, Non-Hodgkin
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
32
|
4
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Lymphoma, Mixed-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Reticulosarcoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
404
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
164
|
15
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |